Trade LEGN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Legend Biotech Corporation American Depositary Shares (LEGN) is trading at US$17.61, up 0.17% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$4.24B. Over the past 52 weeks, LEGN has traded between US$16.24 and US$37.50. On Syfe you can trade LEGN with $0 commission and add it to your watchlist.
| Previous close | US$17.58 |
|---|---|
| Market cap | US$4.24B |
| P/E ratio | 41.27 |
| 52-week range | US$16.24 – US$37.50 |
| Volume | 2.94M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Legend Biotech Corporation American Depositary Shares
Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.
Year: 2020
Sector Update: Healthcare Stocks Advance Late Afternoon
Aug 12, 7:58 PM · MT Newswires
Legend Biotech Shares Fall After Oppenheimer Downgrade
Aug 12, 6:20 PM · MT Newswires
Sector Update: Healthcare Stocks Ease in Afternoon Trading
Aug 12, 5:34 PM · MT Newswires
Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says
Aug 12, 3:58 PM · MT Newswires
Stay on top of LEGN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore